Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome-Reference-Cited by-同舟云学术

Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome

Published:2007-01-24 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Costello Michael F¹,Shrestha Bhushan²,Eden John³,Johnson Neil⁴,Moran Lisa J⁵

Affiliation:

1. School of Women's & Children's Health, Royal Hospital for Women and IVF Australia; Division of Obstetrics & Gynaecology; Barker Street Randwick Sydney Australia NSW 2031

2. University of New South Wales; School of public health and community medicine; 2/137A Parramatta Road Concord NSW Australia 2137

3. Royal Hospital for Women; Sydney Menopause Centre & Natural Therapies Unit; Locked Bag 2000 Randwick NSW Australia 2031

4. University of Auckland; Department of Obstetrics & Gynaecology; PO Box 92019 Auckland New Zealand 1003

5. Monash University; The Jean Hailes Clinical Research Unit, School of Public Health and Preventive Medicine; Locked bag 29, Monash Medical Centre, Clayton Road Clayton Road Clayton Victoria Australia 3168

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005552.pub2/fullpdf

Reference46 articles.

1. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients;Cibula;Human Reproduction,2005

2. Clinical, endocrine and metabolic effects of metformin added to ethinyl-estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study;Elter;Human Reproduction,2002

3. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome;Harborne;The Journal of Clinical Endocrinology & Metabolism,2003

4. Endocrine and metabolic effects of metformin versus ethinyl-estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study;Morin-Papunen;The Journal of Clinical Endocrinology & Metabolism,2000

5. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study;Morin-Papunen;The Journal of Clinical Endocrinology & Metabolism,2003

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine Disorders;Care of Adults with Chronic Childhood Conditions;2024

2. Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin;European Journal of Pharmacology;2023-12

3. Oral contraceptives (OCs) in combination with metformin versus OCs alone on metabolism in nonobese polycystic ovary syndrome: A meta‐analysis and systematic review of randomized controlled trials;Clinical Endocrinology;2023-04-07

4. Metformin effect on internal carotid artery blood flow assessed by area under the curve of carotid artery Doppler in women with polycystic ovarian syndrome;World Journal of Clinical Cases;2023-02-26

5. Polycystic Ovary Syndrome (PCOS): Clinical Features, Risk Factors, Biomarkers, Treatment, and Therapeutic Strategies;Toxicology and Human Health;2023